Advanced search
Publication Cover
Gut Microbes Volume 13, 2021 - Issue 1
Submit an article Journal homepage
10,796
Views
43
CrossRef citations to date
0
Altmetric
Review

The interplay between Helicobacter pylori and gastrointestinal microbiota

Chieh-Chang Chena Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;b Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan;c Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2953-210XView further author information
ORCID Icon,
Jyh-Ming Lioua Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;b Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan;d Department of Medicine, National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, TaiwanCorrespondence[email protected]
[email protected]
View further author information
,
Yi-Chia Leea Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;b Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan;e Department of Medical Research, National Taiwan University Hospital, Taipei, TaiwanView further author information
,
Tzu-Chan Hongf Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanView further author information
,
Emad M El-Omarg Microbiome Research Centre, St George & Sutherland Clinical School, University of New South Wales, Sydney, NSW, AustraliaView further author information
&
Ming-Shiang Wua Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;b Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, TaiwanView further author information
Article: 1909459 | Received 02 Sep 2020, Accepted 19 Mar 2021, Published online: 03 May 2021

References

  • Donia MS, Fischbach MA. Small molecules from the human microbiota. Science. 2015;349(6246):1254766. doi:10.1126/science.1254766.
  • Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–712. doi:10.1038/nrn3346.
  • Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–1273. doi:10.1126/science.1223490.
  • Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136(6):1863–1873. doi:10.1053/j.gastro.2009.01.073.
  • Sipponen P, Kekki M, Seppala K, Siurala M. The relationships between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther. 1996;10(Suppl 1):103–118. doi:10.1046/j.1365-2036.1996.22164011.x.
  • Graham DY. The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet. 1997 author reply 2;350(9070):70–71. doi:10.1016/S0140-6736(05)66278-2.
  • Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113–24 e5. doi:10.1053/j.gastro.2016.01.028.
  • Chiang TH, Chang WJ, Chen SL, Yen AM, Fann JC, Chiu SY, Chen Y-R, Chuang S-L, Shieh C-F, Liu C-Y, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. pp.gutjnl-2020-322200. 2020. doi:10.1136/gutjnl-2020-322200
  • Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis. 2008;198(4):553–560. doi:10.1086/590158.
  • Amedei A, Codolo G, Del Prete G, De Bernard M, D’Elios MM. The effect of Helicobacter pylori on asthma and allergy. J Asthma Allergy. 2010;3:139–147. doi:10.2147/JAA.S8971.
  • Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and long-term safety of H. Pylori Eradication for Gastric Cancer Prevention Cancers (Basel). 2019;11(5):593.
  • Liou JM, Lee YC, Wu MS. Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota. J Gastroenterol Hepatol. 2020;35(7):1107–1116. doi:10.1111/jgh.14992.
  • Gagliardi D, Makihara S, Corsi PR, Viana Ade T, Wiczer MV, Nakakubo S, Mimica LMJ. Microbial flora of the normal esophagus. Dis Esophagus. 1998;11(4):248–250. doi:10.1093/dote/11.4.248.
  • Pajecki D, Zilberstein B, Dos Santos MA, Ja U, Ag Q, Cecconello I. Megaesophagus microbiota: a qualitative and quantitative analysis. J Gastrointest Surg. 2002;6(5):723–729. doi:10.1016/S1091-255X(02)00028-8.
  • Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A. 2004;101(12):4250–4255. doi:10.1073/pnas.0306398101.
  • Park CH, Lee SK. Exploring Esophageal Microbiomes in Esophageal diseases: a systematic review. J Neurogastroenterol Motil. 2020;26(2):171–179. doi:10.5056/jnm19240.
  • Nardone G, Compare D, Rocco A. A microbiota-centric view of diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepatol. 2017;2(4):298–312. doi:10.1016/S2468-1253(16)30108-X.
  • Deshpande NP, Riordan SM, Castano-Rodriguez N, Wilkins MR, Kaakoush NO. Signatures within the esophageal microbiome are associated with host genetics, age, and disease. Microbiome. 2018;6(1):227. doi:10.1186/s40168-018-0611-4.
  • Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137(2):588–597. doi:10.1053/j.gastro.2009.04.046.
  • Liu N, Ando T, Ishiguro K, Maeda O, Watanabe O, Funasaka K, Nakamura M, Miyahara R, Ohmiya N, Goto H, et al. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett’s esophagus. BMC Infect Dis. 2013;13(1):130. doi:10.1186/1471-2334-13-130.
  • Gall A, Fero J, McCoy C, Claywell BC, Sanchez CA, Blount PL, Li X, Vaughan TL, Matsen FA, Reid BJ, et al. Bacterial composition of the human upper gastrointestinal tract microbiome is dynamic and associated with genomic instability in a Barrett’s Esophagus Cohort. PLoS One. 2015;10(6):e0129055. doi:10.1371/journal.pone.0129055.
  • Elliott DRF, Walker AW, O’Donovan M, Parkhill J, Fitzgerald RC. A non-endoscopic device to sample the oesophageal microbiota: a case-control study. Lancet Gastroenterol Hepatol. 2017;2(1):32–42. doi:10.1016/S2468-1253(16)30086-3.
  • Snider EJ, Compres G, Freedberg DE, Khiabanian H, Nobel YR, Stump S, Uhlemann A-C, Lightdale CJ, Abrams JA. Alterations to the Esophageal Microbiome associated with progression from Barrett’s Esophagus to Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1687–1693. doi:10.1158/1055-9965.EPI-19-0008.
  • Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, Bamford KB, Ghazy A, McCarron P, McGuigan J, Reynolds JV, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut. 2008;57(6):734–739. doi:10.1136/gut.2007.132662.
  • Peek RM Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2(1):28–37. doi:10.1038/nrc703.
  • Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Rumore G, Quesenberry C, Buffler P, et al. Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study. Gut. 2008;57(6):727–733. doi:10.1136/gut.2007.132068.
  • Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP. Helicobacter pylori infection is associated with reduced risk of Barrett’s Esophagus: an analysis of the Barrett’s and Esophageal Adenocarcinoma consortium. Am J Gastroenterol. 2018;113(8):1148–1155. doi:10.1038/s41395-018-0070-3.
  • Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE. Gastric microbiota is altered in oesophagitis and Barrett’s oesophagus and further modified by proton pump inhibitors. Environ Microbiol. 2014;16(9):2905–2914. doi:10.1111/1462-2920.12285.
  • Yang I, Nell S, Suerbaum S. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev. 2013;37(5):736–761. doi:10.1111/1574-6976.12027.
  • Stockbruegger RW. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol Suppl. 1985;111(sup111):7–16. doi:10.3109/00365528509093749.
  • Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, Duroux P, Nicolet M, Pignatelli B, Blum AL, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39(1):54–59. doi:10.1136/gut.39.1.54.
  • Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. doi:10.1038/nature11234.
  • Monstein HJ, Tiveljung A, Kraft CH, Borch K, Jonasson J. Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis. J Med Microbiol. 2000;49(9):817–822. doi:10.1099/0022-1317-49-9-817.
  • Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A. 2006;103(3):732–737. doi:10.1073/pnas.0506655103.
  • Li XX, Wong GL, To KF, Wong VW, Lai LH, Chow DK, Lau JYW, Sung JJY, Ding C. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One. 2009;4(11):e7985. doi:10.1371/journal.pone.0007985.
  • Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, Andersen L, Machado JC, Ianiro G, Gasbarrini A, et al. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 2020;51(6):582–602. doi:10.1111/apt.15650.
  • Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, Wurm P, Gorkiewicz G, Högenauer C, Pieber TR, et al. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr. 2016;55(4):1479–1489. doi:10.1007/s00394-015-0966-2.
  • Stearns JC, Lynch MD, Senadheera DB, Tenenbaum HC, Goldberg MB, Cvitkovitch DG, Croitoru K, Moreno-Hagelsieb G, Neufeld JD. Bacterial biogeography of the human digestive tract. Sci Rep. 2011;1(1):170. doi:10.1038/srep00170.
  • Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, Beck JM, Curtis JL, Huffnagle GB. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio. 2015;6(2):e00037. doi:10.1128/mBio.00037-15.
  • Al-Momani H, Perry A, Stewart CJ, Jones R, Krishnan A, Robertson AG, Bourke S, Doe S, Cummings SP, Anderson A, et al. Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients. Sci Rep. 2016;6(1):26985. doi:10.1038/srep26985.
  • Edgar RC. Accuracy of microbial community diversity estimated by closed- and open-reference OTUs. PeerJ. 2017;5:e3889. doi:10.7717/peerj.3889.
  • Scott DR, Marcus EA, Weeks DL, Sachs G. Mechanisms of acid resistance due to the urease system of Helicobacter pylori. Gastroenterology. 2002;123(1):187–195. doi:10.1053/gast.2002.34218.
  • Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L, Ahmed N. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One. 2008;3(7):e2836. doi:10.1371/journal.pone.0002836.
  • Li TH, Qin Y, Sham PC, Lau KS, Chu KM, Leung WK. Alterations in gastric microbiota after H. Pylori Eradication and in Different Histological Stages of Gastric Carcinogenesis Sci Rep. 2017;7:44935.
  • Klymiuk I, Bilgilier C, Stadlmann A, Thannesberger J, Kastner M-T, Hogenauer C, Püspök A, Biowski-Frotz S, Schrutka-Kölbl C, Thallinger GG, et al. The human gastric microbiome is predicated upon infection with Helicobacter pylori. Front Microbiol. 2017;8:2508. doi:10.3389/fmicb.2017.02508.
  • Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC, Figueiredo C. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67(2):226–236. doi:10.1136/gutjnl-2017-314205.
  • Vasapolli R, Schutte K, Schulz C, Vital M, Schomburg D, Pieper DH, Vilchez-Vargas R, Malfertheiner P. Analysis of transcriptionally active bacteria throughout the gastrointestinal tract of healthy individuals. Gastroenterology. 2019;157(4):1081–92 e3. doi:10.1053/j.gastro.2019.05.068.
  • Llorca L, Perez-Perez G, Urruzuno P, Martinez MJ, Iizumi T, Gao Z, Sohn J, Chung J, Cox L, Simón-Soro A, et al. Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori status. Pediatr Infect Dis J. 2017;36(2):173–178. doi:10.1097/INF.0000000000001383.
  • Miftahussurur M, Waskito LA, El-Serag HB, Ajami NJ, Nusi IA, Syam AF. Gastric microbiota and Helicobacter pylori in Indonesian population. In: Helicobacter. 2020. p.e12695.
  • Miao R, Wan C, Wang Z. The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population. Helicobacter. 2020;25(1):e12676. doi:10.1111/hel.12676.
  • Zhao Y, Gao X, Guo J, Yu D, Xiao Y, Wang H, Li Y. Helicobacter pylori infection alters gastric and tongue coating microbial communities. Helicobacter. 2019;24(2):e12567. doi:10.1111/hel.12567.
  • Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ, Brodie EL, Dominguez-Bello MG. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. Isme J. 2011;5(4):574–579. doi:10.1038/ismej.2010.149.
  • Martin ME, Bhatnagar S, George MD, Paster BJ, Canfield DR, Eisen JA, Solnick JV. The impact of Helicobacter pylori infection on the gastric microbiota of the rhesus macaque. PLoS One. 2013;8(10):e76375. doi:10.1371/journal.pone.0076375.
  • He C, Peng C, Wang H, Ouyang Y, Zhu Z, Shu X, Zhu Y, Lu N. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults. Helicobacter. 2019;24:e12590. doi:10.1111/hel.12590.
  • Guo Y, Zhang Y, Gerhard M, Gao JJ, Mejias-Luque R, Zhang L. Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer. Gut. 2019;69(9):1598–1607.
  • Sung JJY, Coker OO, Chu E, Szeto CH, Luk STY, Lau HCH, Yu J. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut. 2020;69(9):1572–1581. doi:10.1136/gutjnl-2019-319826.
  • IARC working group on the evaluation of carcinogenic risks to humans. some industrial chemicals. IARC Monogr Eval Carcinog Risks Hum. Lyon, 15-22 February 1994. 1994;60:1–560.
  • Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19:S37–43.
  • Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis results of a 32-year follow-up study. Scand J Gastroenterol. 1996;31(6):546–550. doi:10.3109/00365529609009126.
  • Sipponen P, Kekki M, Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a Representative Population Sample Cancer. 1983;52:1062–1068.
  • Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–789. doi:10.1056/NEJMoa001999.
  • Chen HN, Wang Z, Li X, Zhou ZG. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer. 2016;19(1):166–175. doi:10.1007/s10120-015-0462-7.
  • Amieva M, Peek RM Jr. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150(1):64–78. doi:10.1053/j.gastro.2015.09.004.
  • Hewetson JT. Report LXXXVIII: the bacteriology of certain parts of the human alimentary canal and of the inflammatory processes arising therefrom. Br Med J. 1904;2(2291):1457–1460. doi:10.1136/bmj.2.2291.1457.
  • Barber M, Franklin RH. Bacteriology of peptic ulcer and gastric carcinoma. Br Med J. 1946;1(4459):951–953. doi:10.1136/bmj.1.4459.951.
  • Cregan J, Dunlop EE, Hayward NJ. The bacterial content of human small intestine in disease of the stomach. Br Med J. 1953;2(4848):1248–1251. doi:10.1136/bmj.2.4848.1248.
  • Gatehouse D, Dimock F, Burdon DW, Alexander-Williams J, Keighley MR. Prediction of wound sepsis following gastric operations. Br J Surg. 1978;65(8):551–554. doi:10.1002/bjs.1800650808.
  • Sjostedt S, Heimdahl A, Kager L, Nord CE. Microbial colonization of the oropharynx, esophagus and stomach in patients with gastric diseases. Eur J Clin Microbiol. 1985;4(1):49–51. doi:10.1007/BF02148660.
  • Rosenow EC, Sanford AH. The bacteriology of ulcer of the stomach and duodenum in man. Journal of Infectious Diseases. 1915;17(1):219–U12. doi:10.1093/infdis/17.1.219.
  • Kato S, Fujimura S, Kimura K, Nishio T, Hamada S, Minoura T, Oda M. Non-Helicobacter bacterial flora rarely develops in the gastric mucosal layer of children. Dig Dis Sci. 2006;51(4):641–646. doi:10.1007/s10620-006-3185-0.
  • Engstrand L, Lindberg M. Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol. 2013;27(1):39–45. doi:10.1016/j.bpg.2013.03.016.
  • Dicksved J, Lindberg M, Rosenquist M, Enroth H, Jansson JK, Engstrand L. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol. 2009;58(4):509–516. doi:10.1099/jmm.0.007302-0.
  • Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep. 2015;4(1):4202. doi:10.1038/srep04202.
  • Eun CS, Kim BK, Han DS, Kim SY, Kim KM, Choi BY, Song KS, Kim YS, Kim JF. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods. Helicobacter. 2014;19(6):407–416. doi:10.1111/hel.12145.
  • Wang L, Zhou J, Xin Y, Geng C, Tian Z, Yu X, Dong Q. Bacterial overgrowth and diversification of microbiota in gastric cancer. Eur J Gastroenterol Hepatol. 2016;28(3):261–266. doi:10.1097/MEG.0000000000000542.
  • Jo HJ, Kim J, Kim N, Park JH, Nam RH, Seok YJ, Kim Y-R, Kim JS, Kim JM, Kim JM, et al. Analysis of gastric microbiota by pyrosequencing: minor role of bacteria other than Helicobacter pylori in the gastric carcinogenesis. Helicobacter. 2016;21(5):364–374. doi:10.1111/hel.12293.
  • Yu G, Torres J, Hu N, Medrano-Guzman R, Herrera-Goepfert R, Humphrys MS, Wang L, Wang C, Ding T, Ravel J, et al. Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol. 2017;7:302. doi:10.3389/fcimb.2017.00302.
  • Castano-Rodriguez N, Goh KL, Fock KM, Mitchell HM, Kaakoush NO. Dysbiosis of the microbiome in gastric carcinogenesis. Sci Rep. 2017;7(1):15957. doi:10.1038/s41598-017-16289-2.
  • Hsieh YY, Tung SY, Pan HY, Yen CW, Xu HW, Lin YJ, Deng Y-F, Hsu W-T, Wu C-S, Li C, et al. Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci Rep. 2018;8(1):158. doi:10.1038/s41598-017-18596-0.
  • Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G, Wu WK, Wong SH, Chen Z, Sung JJY, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 2018;67(6):1024–1032. doi:10.1136/gutjnl-2017-314281.
  • Hu YL, Pang W, Huang Y, Zhang Y, Zhang CJ. The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics. Front Cell Infect Microbiol. 2018;8:433. doi:10.3389/fcimb.2018.00433.
  • Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng Y, Liu F, Yan C, Li L, Ling Z, et al. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine. 2019;40:336–348. doi:10.1016/j.ebiom.2018.12.034.
  • Gunathilake MN, Lee J, Choi IJ, Kim YI, Ahn Y, Park C, Kim J. Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study. Sci Rep. 2019;9(1):13589. doi:10.1038/s41598-019-50054-x.
  • Park CH, Lee AR, Lee YR, Eun CS, Lee SK, Han DS. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing. Helicobacter. 2019;24(1):e12547. doi:10.1111/hel.12547.
  • Wu ZF, Zou K, Wu GN, Jin ZJ, Xiang CJ, Xu S, Wang Y-H, Wu X-Y, Chen C, Xu Z, et al. A comparison of tumor-associated and non-tumor-associated gastric microbiota in gastric cancer patients. Dig Dis Sci. 2020. doi:10.1007/s10620-020-06415-y.
  • Gantuya B, El Serag HB, Matsumoto T, Ajami NJ, Uchida T, Oyuntsetseg K, Bolor D, Yamaoka Y. Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. Aliment Pharmacol Ther. 2020;51(8):770–780. doi:10.1111/apt.15675.
  • Stewart OA, Wu F, Chen Y. The role of gastric microbiota in gastric cancer. Gut Microbes. 2020;11(5):1220–1230. doi:10.1080/19490976.2020.1762520.
  • Rodriguez RM, Hernandez BY, Menor M, Deng Y, Khadka VS. The landscape of bacterial presence in tumor and adjacent normal tissue across 9 major cancer types using TCGA exome sequencing. Comput Struct Biotechnol J. 2020;18:631–641. doi:10.1016/j.csbj.2020.03.003.
  • Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, Potter A, Varro A, Eibach D, Suerbaum S, et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology. 2011;140(1):210–220. doi:10.1053/j.gastro.2010.09.048.
  • Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, Ge Z, Wang TC, Fox JG. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63(1):54–63. doi:10.1136/gutjnl-2013-305178.
  • Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533.
  • Kienesberger S, Cox LM, Livanos A, Zhang XS, Chung J, Perez-Perez GI, Gorkiewicz G, Zechner E, Blaser M. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep. 2016;14(6):1395–1407. doi:10.1016/j.celrep.2016.01.017.
  • Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M, et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest. 2012;122(3):1082–1096. doi:10.1172/JCI61029.
  • Heimesaat MM, Fischer A, Plickert R, Wiedemann T, Loddenkemper C, Gobel UB, Bereswill S, Rieder G. Helicobacter pylori induced gastric immunopathology is associated with distinct microbiota changes in the large intestines of long-term infected Mongolian gerbils. PLoS One. 2014;9(6):e100362. doi:10.1371/journal.pone.0100362.
  • Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011;340(1):44–58. doi:10.1016/j.mce.2011.04.019.
  • La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol. 2004;4(5):371–379. doi:10.1038/nri1350.
  • Muhsen K, Goren S, Cohen D. Helicobacter pylori infection in early childhood and growth at school age. Helicobacter. 2015;20(6):410–417. doi:10.1111/hel.12227.
  • Buhling A, Radun D, Muller WA, Malfertheiner P. Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. Aliment Pharmacol Ther. 2001;15(9):1445–1452. doi:10.1046/j.1365-2036.2001.01033.x.
  • Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S, Korpela R. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int J Antimicrob Agents. 2007;29(1):66–72. doi:10.1016/j.ijantimicag.2006.08.034.
  • Yang YJ, Sheu BS. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children. Helicobacter. 2012;17(4):297–304. doi:10.1111/j.1523-5378.2012.00941.x.
  • Chen L, Xu W, Lee A, He J, Huang B, Zheng W, Su T, Lai S, Long Y, Chu H, et al. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, randomized clinical trial. EBioMedicine. 2018;35:87–96. doi:10.1016/j.ebiom.2018.08.028.
  • Iino C, Shimoyama T, Chinda D, Arai T, Chiba D, Nakaji S, Fukuda S. Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in gut microbiota in a Japanese population. Front Immunol. 2018;9:712. doi:10.3389/fimmu.2018.00712.
  • Benavides-Ward A, Vasquez-Achaya F, Silva-Caso W, Aguilar-Luis MA, Mazulis F, Urteaga N, Del Valle-mendoza J. Helicobacter pylori and its relationship with variations of gut microbiota in asymptomatic children between 6 and 12 years. BMC Res Notes. 2018;11(1):468. doi:10.1186/s13104-018-3565-5.
  • Gao JJ, Zhang Y, Gerhard M, Mejias-Luque R, Zhang L, Vieth M, Ma J-L, Bajbouj M, Suchanek S, Liu W-D, et al. Association between gut microbiota and Helicobacter pylori-related gastric lesions in a high-risk population of gastric cancer. Front Cell Infect Microbiol. 2018;8:202. doi:10.3389/fcimb.2018.00202.
  • Osaki T, Zaman C, Yonezawa H, Lin Y, Okuda M, Nozaki E, Hojo F, Kurata S, Hanawa T, Kikuchi S, et al. Influence of intestinal indigenous microbiota on intrafamilial infection by Helicobacter pylori in Japan. Front Immunol. 2018;9:287. doi:10.3389/fimmu.2018.00287.
  • Iino C, Shimoyama T, Chinda D, Sakuraba H, Fukuda S, Nakaji S. Influence of Helicobacter pylori infection and atrophic gastritis on the gut microbiota in a Japanese population. Digestion. 2019;101(4):422–432.
  • Wang D, Li Y, Zhong H, Ding Q, Lin Y, Tang S, Zong Y, Wang Q, Zhang X, Yang H, et al. Alterations in the human gut microbiome associated with Helicobacter pyloriinfection. FEBS Open Bio. 2019;9(9):1552–1560. doi:10.1002/2211-5463.12694.
  • Dash NR, Khoder G, Nada AM, Al Bataineh MT, Yamaoka Y. Exploring the impact of Helicobacter pylori on gut microbiome composition. PLoS One. 2019;14(6):e0218274. doi:10.1371/journal.pone.0218274.
  • Yang L, Zhang J, Xu J, Wei X, Yang J, Liu Y. Helicobacter pylori infection aggravates dysbiosis of gut microbiome in children with gastritis. Front Cell Infect Microbiol. 2019;9:375. doi:10.3389/fcimb.2019.00375.
  • Frost F, Kacprowski T, Ruhlemann M, Bang C, Franke A, Zimmermann K, Nauck M, Völker U, Völzke H, Biffar R, et al. Helicobacter pylori infection associates with fecal microbiota composition and diversity. Sci Rep. 2019;9(1):20100. doi:10.1038/s41598-019-56631-4.
  • Cornejo-Pareja I, Martin-Nunez GM, Roca-Rodriguez MM, Cardona F, Coin-Araguez L, Sanchez-Alcoholado L, Gutiérrez-Repiso C, Muñoz-Garach A, Fernández-García J, Moreno-Indias I, et al. H. pylori eradication treatment alters gut microbiota and GLP-1 secretion in humans. J Clin Med. 2019;8(4):451. doi:10.3390/jcm8040451.
  • Zhou Y, Ye Z, Lu J, Miao S, Lu X, Sun H. Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children. Helicobacter. 2020;25(5):e12721. doi: 10.1111/hel.12721. Epub 2020 Jul 12.
  • Seley GP, Colp R. The bacteriology of peptic ulcers and gastric malignancies - possible bearing on complications following gastric surgery. Surgery. 1941;10:369–380.
  • Sjostedt S, Kager L, Heimdahl A, Nord CE. Microbial colonization of tumors in relation to the upper gastrointestinal tract in patients with gastric carcinoma. Ann Surg. 1988;207(3):341–346. doi:10.1097/00000658-198803000-00020.
  • Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016;65(11):1906–1915. doi:10.1136/gutjnl-2016-312297.
  • Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L, Ratner AJ. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010;5(3):e9836. doi:10.1371/journal.pone.0009836.
  • Yap TW, Gan HM, Lee YP, Leow AH, Azmi AN, Francois F, Perez-Perez GI, Loke M-F, Goh K-L, Vadivelu J, et al. Helicobacter pylori eradication causes perturbation of the human gut microbiome in young adults. PLoS One. 2016;11(3):e0151893. doi:10.1371/journal.pone.0151893.
  • Oh B, Kim BS, Kim JW, Kim JS, Koh SJ, Kim BG, Lee KL, Chun J. The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial. Helicobacter. 2016;21(3):165–174. doi:10.1111/hel.12270.
  • Yanagi H, Tsuda A, Matsushima M, Takahashi S, Ozawa G, Koga Y, Takagi A. Changes in the gut microbiota composition and the plasma ghrelin level in patients with Helicobacter pylori-infected patients with eradication therapy. BMJ Open Gastroenterol. 2017;4(1):e000182. doi:10.1136/bmjgast-2017-000182.
  • Hsu PI, Pan CY, Kao JY, Tsay FW, Peng NJ, Kao SS, Wang H-M, Tsai T-J, Wu D-C, Chen C-L, et al. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria. Helicobacter. 2018;23(4):e12498. doi:10.1111/hel.12498.
  • Gotoda T, Takano C, Kusano C, Suzuki S, Ikehara H, Hayakawa S, Andoh A. Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers. Helicobacter. 2018;23(6):e12541. doi:10.1111/hel.12541.
  • Liou JM, Chen CC, Chang CM, Fang YJ, Bair MJ, Chen PY, Chang C-Y, Hsu Y-C, Chen M-J, Chen -C-C, et al. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. Lancet Infect Dis. 2019;19(10):1109–1120. doi:10.1016/S1473-3099(19)30272-5.
  • Martin-Nunez GM, Cornejo-Pareja I, Coin-Araguez L, Mdm R-R, Munoz-Garach A, Clemente-Postigo M, Cardona F, Moreno-Indias I, Tinahones FJ. H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota. PLoS One. 2019;14(3):e0213548. doi:10.1371/journal.pone.0213548.
  • Hsu PI, Pan CY, Kao JY, Tsay FW, Peng NJ, Kao SS, Chen Y-H, Tsai T-J, Wu D-C, Tsai K-W, et al. Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota. J Gastroenterol Hepatol. 2019;34(11):1968–1976. doi:10.1111/jgh.14736.
  • Ye Q, Shao X, Shen R, Chen D, Shen J. Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: a systematic review and meta-analysis. Helicobacter. 2020;25(4):e12713. doi:10.1111/hel.12713.
  • Franceschi F, Zuccala G, Roccarina D, Gasbarrini A. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol. 2014;11(4):234–242. doi:10.1038/nrgastro.2013.243.
  • Satoh H, Saijo Y, Yoshioka E, Tsutsui H. Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb. 2010;17(10):1041–1048. doi:10.5551/jat.5157.
  • Upala S, Sanguankeo A, Saleem SA, Jaruvongvanich V. Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(2):153–159. doi:10.1097/MEG.0000000000000774.
  • Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K, et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab. 2005;90(1):10–16. doi:10.1210/jc.2004-1330.
  • tAbdel-Razik A, Mousa N, Shabana W, Refaey M, Elhelaly R, Elzehery R, Abdelsalam M, Elgamal A, Nassar MR, Abu El‐Soud A, et al. Helicobacter pylori and non-alcoholic fatty liver disease: a new enigma? Helicobacter. 2018;23(6):e12537. doi:10.1111/hel.12537.
  • He C, Yang Z, Cheng D, Xie C, Zhu Y, Ge Z, Luo Z, Lu N. Helicobacter pylori infection aggravates diet-induced insulin resistance in association with gut microbiota of Mice. EBioMedicine. 2016;12:247–254. doi:10.1016/j.ebiom.2016.09.010.
  • Chen Y, Blaser MJ, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007;167(8):821–827. doi:10.1001/archinte.167.8.821.
  • El-omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, McColl KE. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut. 1994;35(10):1385–1388. doi:10.1136/gut.35.10.1385.
  • Castano-Rodriguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut. 2017;66(2):235–249. doi:10.1136/gutjnl-2015-310545.
  • Dogra S, Sakwinska O, Soh SE, Ngom-Bru C, Bruck WM, Berger B, Brüssow H, Lee YS, Yap F, Chong Y-S, et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. mBio. 2015;6(1). doi:10.1128/mBio.02419-14.
  • Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, Yamaoka Y, Berenson GS. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002;359(9310):931–935. doi:10.1016/S0140-6736(02)08025-X.
  • Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227. doi:10.1038/nature11053.
  • Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology. 2010;138(3):1046–1054. doi:10.1053/j.gastro.2009.11.043.
  • Yu Y, Zhu S, Li P, Min L, Zhang S. Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis. 2018;9(10):961. doi:10.1038/s41419-018-0982-2.
  • Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Müller A. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest. 2011;121(8):3088–3093. doi:10.1172/JCI45041.
  • Izcue A, Coombes JL, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev. 2006;212(1):256–271. doi:10.1111/j.0105-2896.2006.00423.x.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.